Antengene (HK: 6996) has announced that its multiple myeloma treatment, Xpovio (selinexor), will be included in Taiwan’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback